Premium infant formula under FDA spotlight after botulism cases
FDA investigations are underway into infant botulism outbreaks linked to premium formulas ByHeart and Nara Organics, focusing on whole-milk powder as a potential risk and raising questions about safety claims versus scientific risk. Experts say all powdered infant formulas share safety requirements, and marketing distinctions (organic, probiotics, etc.) don’t guarantee safety. The cases highlight oversight gaps in a market dominated by a few players, prompting calls for stronger industry guidance and more competition, with no deaths reported but hospitalizations and ongoing parental anxiety.